Health Canada drug identification number

DIN 02082152 — GENTAMICIN(E) 1.6 MG

GENTAMICIN(E) is a solution of Gentamicin marketed by BAXTER CORPORATION. The full Gentamicin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02082152
Brand name
GENTAMICIN(E)
Active ingredient
Gentamicin
Strength
1.6 MG
Dosage form
SOLUTION
Route
INTRAVENOUS
Manufacturer
BAXTER CORPORATION
Health Canada status
MARKETED
Drug class
Aminoglycoside antibiotic

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Gentamicin products

DINBrandStrengthFormManufacturerStatus
02268531 GENTAMICIN INJECTION USP 10 MG SOLUTION SANDOZ CANADA INCORPORATED MARKETED
02470462 GENTAMICIN INJECTION USP 10 MG SOLUTION HIKMA CANADA LIMITED MARKETED
02242652 GENTAMICIN INJECTION USP 40 MG SOLUTION SANDOZ CANADA INCORPORATED MARKETED
02457008 GENTAMICIN INJECTION USP 40 MG SOLUTION HIKMA CANADA LIMITED MARKETED
02082136 GENTAMICIN(E) 1 MG SOLUTION BAXTER CORPORATION MARKETED
00832162 ODAN-GENTAMICIN 5 MG SOLUTION ODAN LABORATORIESLTD DORMANT
01989073 ODAN-GENTAMICIN 5 MG OINTMENT ODAN LABORATORIESLTD DORMANT

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.